Marker Therapeutics, Inc. SC 13D and SC 13D/A reports

Location
2450 Holcombe Blvd, Suite Bcm A, Ms: Bcm251, Houston, TX
State of incorporation
Delaware
Fiscal year end
December 31
Data updated at
8/15/2024, 01:34 AM
Form type Sec Links Description Filing date Reporting date
SC 13D/A Report NEW ENTERPRISE ASSOCIATES 16, L.P. / MARKER THERAPEUTICS, INC. -- SCHEDULE 13D/A May 17, 2024
SC 13D/A Report AMENDMENT NO. 1 TO SCHEDULE 13D Mar 3, 2023
SC 13D/A Report NEW ENTERPRISE ASSOCIATES 16, L.P. (MARKER THERAPEUTICS) - SCHEDULE 13DA1 Mar 26, 2021
SC 13D/A Report SC 13D/A Mar 24, 2021
SC 13D/A Report SCHEDULE 13D/A Mar 15, 2021
SC 13D/A Report SCHEDULE 13D/A Nov 13, 2020
SC 13D/A Report SCHEDULE 13D/A Jun 18, 2020
SC 13D/A Report SCHEDULE 13 D/A Feb 20, 2020
SC 13D Report SC 13D Feb 14, 2019
SC 13D Report SC 13D Feb 14, 2019
SC 13D Report SC 13D Feb 14, 2019
SC 13D/A Report SCHEDULE 13D/A Nov 8, 2018
SC 13D Report NEW ENTERPRISE ASSOCIATES 16, L.P. - MARKER THERAPEUTICS, INC. 13D Oct 25, 2018
SC 13D Report SCHEDULE 13D Oct 19, 2018
SC 13D/A Report SCHEDULE 13D/A May 16, 2018
SC 13D Report Apr 4, 2018
SC 13D Report SCHEDULE 13D/A Aug 25, 2017
SC 13D/A Report SCHEDULE 13D/A Aug 12, 2016
SC 13D/A Report SCHEDULE 13D/A Sep 29, 2015
SC 13D/A Report SCHEDULE 13D/A Sep 11, 2015
SC 13D/A Report SCHEDULE 13D/A Jun 18, 2015
SC 13D/A Report SCHEDULE 13D/A Jun 5, 2015
SC 13D/A Report SCHEDULE 13D/A Jun 3, 2015
SC 13D Report Mar 17, 2015
SC 13D Report Feb 27, 2013
SC 13D Report SCHEDULE 13D Jan 7, 2013